13-112486096-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_006322.6(TUBGCP3):c.2621G>A(p.Arg874Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000193 in 1,610,138 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006322.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TUBGCP3 | ENST00000261965.8 | c.2621G>A | p.Arg874Gln | missense_variant | Exon 22 of 22 | 1 | NM_006322.6 | ENSP00000261965.3 | ||
TUBGCP3 | ENST00000469302.1 | n.299G>A | non_coding_transcript_exon_variant | Exon 2 of 2 | 2 | |||||
TUBGCP3 | ENST00000649778.1 | n.*984G>A | non_coding_transcript_exon_variant | Exon 23 of 23 | ENSP00000497715.1 | |||||
TUBGCP3 | ENST00000649778.1 | n.*984G>A | 3_prime_UTR_variant | Exon 23 of 23 | ENSP00000497715.1 |
Frequencies
GnomAD3 genomes AF: 0.000355 AC: 54AN: 152168Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000180 AC: 44AN: 244034Hom.: 0 AF XY: 0.000227 AC XY: 30AN XY: 132024
GnomAD4 exome AF: 0.000176 AC: 256AN: 1457970Hom.: 0 Cov.: 30 AF XY: 0.000167 AC XY: 121AN XY: 725124
GnomAD4 genome AF: 0.000355 AC: 54AN: 152168Hom.: 0 Cov.: 33 AF XY: 0.000498 AC XY: 37AN XY: 74330
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2621G>A (p.R874Q) alteration is located in exon 22 (coding exon 22) of the TUBGCP3 gene. This alteration results from a G to A substitution at nucleotide position 2621, causing the arginine (R) at amino acid position 874 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at